On May 25, 2016, the Weill Department of Medicine (WDOM) hosted the third Quality Improvement and Patient Safety (QIPS) Poster Session to share results of the many innovative projects conceived and led by WDOM faculty and residents. This year's event showcased five projects internally funded by the WDOM and also included thirteen independent posters from abstracts selected during an open call for abstracts earlier this year.
Research from the Artis Lab, leading a five-institution collaboration, has uncovered a pivotal finding implicating a metabolic pathway that promotes allergic inflammation in the lung. The groundbreaking studies, published in Nature Immunology, identify that an enzyme, Arginase-1, changes the metabolism within ILCs, a recently identified class of innate immune cells.
The New York Academy of Medicine has announced that the Glorney-Raisbeck Fellowship in Cardiovascular Diseases has been awarded to Dr. Parag Goyal. Dr. Goyal, currently a fellow in the Division of Cardiology, trained in internal medicine at NewYork-Presbyterian/Weill Cornell Medicine.
Dr. Gregory F. Sonnenberg, a member of the Roberts Institute for Research in IBD, has led an international team that developed an innovative therapeutic approach that blocked production of an inflammation-promoting molecule in mice – but left key protective immune factors intact. This breakthrough has provided promise for a new approach for the treatment of IBD.
As Vice Chair for Basic and Translational Research, Dr. Lipkin will work closely with departmental and divisional leadership to enhance and foster the research activities of our faculty and trainees.
The researchers have uncovered a self-repair mechanism that could lead to innovative approaches for the treatment of inflammatory bowel diseases and other intestinal disorders. The article in PNAS reveals findings on a mechanism that allows the single layer of cells that line the inside of the intestines to signal the immune system to repair tissue damage. A defect in this repair system underlies Crohn's disease and ulcerative colitis.
Challenging widespread clinical practice and accepted treatment guidelines, Dr. Holly Prigerson has published a paper in JAMA Oncology that puts the value of chemotherapy for end-of-life patients with cancer into question. Among several findings, it was found that patients who were ambulatory (able to do light work) and receiving chemotherapy at study entry, had significantly lower quality of life at the end of their lives compared to those who were not receiving chemotherapy.
The Mayo Clinic has received an $11 million grant from the National Cancer Institute to support research addressing current and long-term unmet healthcare needs of people with non-Hodgkin lymphoma (NHL). The is a collaborative effort among multiple institutions.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research. It is supported by the Michael Wolk Foundation.
Initiated in 2002, the Fellow Award in Research is presented annually to fellows within the Weill Department of Medicine who have presented outstanding research. This year's finalists were announced at the June 10 Medicine Grand Rounds (13th Annual).
